Andrew Faughnan | executive |
Bradley Campbell | executive |
Sebastien Martel | executive |
Jeffrey Castelli | executive |
Simon Nicolas Harford | executive |
Anupam Rama | analyst |
Eliana Merle | analyst |
Kristen Kluska | analyst |
Tazeen Ahmad | analyst |
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics First Quarter 2024 Financial Results Conference Call and Webcast. [Operator Instructions] As a reminder, conference is being recorded. I would now like to turn the conference over to your host, Mr. Andrew Faughnan, Vice President of Investor Relations.
You may begin.
Thank you, [ Hill ].